Ketamine as adjuvant to opioids for cancer pain. A qualitative systematic review.
about
Ketamine for pain in adults and children with cancer: a systematic review and synthesis of the literatureAdverse Effects of Opioids on the Central Nervous Systems of Palliative Care PatientsKetamine for chronic pain: risks and benefits.Selective enhancement of fentanyl-induced antinociception by the delta agonist SNC162 but not by ketamine in rhesus monkeys: Further evidence supportive of delta agonists as candidate adjuncts to mu opioid analgesics.Improving opioid effectiveness: from ideas to evidence.Methadone for cancer pain: what have we learned from clinical studies?NMDA receptors in clinical neurology: excitatory times ahead.Chronic administration of ketamine for analgesia.Managing acute pain in opioid tolerant patients.Low-dose ketamine as a potential adjuvant therapy for painful vaso-occlusive crises in sickle cell disease.Ketamine in pain management.Clinical guideline for pharmacological management of cancer pain: the Japanese Society of Palliative Medicine recommendations.Managing difficult pain conditions in the cancer patient.Opioid adjuvant strategy: improving opioid effectiveness.Ketamine for Treatment of Suicidal Ideation and Reduction of Risk for Suicidal Behavior.Role of Ketamine and Methadone as Adjunctive Therapy in Complex Pain Management: A Case Report and Literature ReviewLong-Term Intravenous Ketamine for Analgesia in a Child with Severe Chronic Intestinal Graft versus Host Disease.Intracerebroventricular morphine for refractory cancer pain: transitioning to the home setting.Clarithromycin, a potent inhibitor of CYP3A, greatly increases exposure to oral S-ketamine.Effects of low-dose intranasal (S)-ketamine in patients with neuropathic pain.Prospective audit of short-term concurrent ketamine, opioid and anti-inflammatory ('triple-agent') therapy for episodes of acute on chronic pain.Ketamine as an adjunct to patient-controlled analgesia: why, for whom, and how much?S-ketamine concentrations are greatly increased by grapefruit juice.St John's wort greatly decreases the plasma concentrations of oral S-ketamine.Beneficial effect of low-dose ketamine addition to epidural administration of morphine-bupivacaine mixture for cancer pain in two cases.Impact of Hospital-Wide Comprehensive Pain Management Initiatives.
P2860
Q27007770-A2E5327A-B682-4D5A-8DCE-2185EBC1EBFBQ29029910-FADD60F8-AD6F-4417-835D-15ADA6559677Q33582045-6A398BB3-FCD2-45C5-B466-C39EED7CC906Q34256805-562CEFB7-A76B-4956-94B8-551E408898C7Q36057741-B75B60CA-B6F1-4DF8-8C53-2757F7F5A09AQ36135137-98B03791-5DCA-449A-90BD-184F26C20447Q36660216-3F5D7095-0AE2-4DFA-BE13-558C6623E0EFQ36790314-776196D6-5BE3-45F3-8CD6-15A3A46C1260Q37340129-24511C46-0E02-411B-860D-4429A0A28AD6Q38097075-3DFD49E0-045C-450A-9705-942A3219D0FEQ38105649-D5CB1B6C-B660-49C3-BEA0-15E0B828F4FBQ38124029-B132B7D9-5625-47F3-97D3-AA7CF462A77FQ38177185-8F22386E-2038-4405-9EE7-0831F0A070E1Q38742586-F7ED229B-BE35-4CBB-ADED-B5A977F9CAE9Q38837851-0FC2F9A7-BDAA-49DD-8381-B0CAB6FF7255Q39143423-16E123DB-87F8-42A1-883C-7E3ABBFD3A2FQ43121042-4F5FA635-C12C-4C12-A2FE-A949C93AE976Q43183438-3F5945C1-F6D1-4CEB-8544-4FCCA51EF809Q43246296-789A7C4D-205D-4A21-9134-A1A81E0AC203Q43280523-72C34A89-F72A-40DF-8393-C692DA205A55Q44347860-94B74DCF-9C7B-438F-9AD5-31D1F24636EFQ47622997-8B21E380-4EDD-4043-BDE5-29A2D0057D9AQ48191586-90E0F0E7-C4BC-4AE5-BA06-E00DC70DF0AFQ48258575-610C9C8F-2789-45EB-97CF-202312E71091Q48705623-8984EBF3-9AC8-401C-99FA-9DBF837CC288Q48726338-1D68B479-1AD9-454B-AF72-9A537629B373
P2860
Ketamine as adjuvant to opioids for cancer pain. A qualitative systematic review.
description
2003 nî lūn-bûn
@nan
2003 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Ketamine as adjuvant to opioids for cancer pain. A qualitative systematic review.
@ast
Ketamine as adjuvant to opioids for cancer pain. A qualitative systematic review.
@en
type
label
Ketamine as adjuvant to opioids for cancer pain. A qualitative systematic review.
@ast
Ketamine as adjuvant to opioids for cancer pain. A qualitative systematic review.
@en
prefLabel
Ketamine as adjuvant to opioids for cancer pain. A qualitative systematic review.
@ast
Ketamine as adjuvant to opioids for cancer pain. A qualitative systematic review.
@en
P1476
Ketamine as adjuvant to opioids for cancer pain. A qualitative systematic review.
@en
P2093
Eija Kalso
Rae F Bell
P304
P356
10.1016/S0885-3924(03)00311-7
P577
2003-09-01T00:00:00Z